Yang, KY. Abnormal pap smear and cervical cancer in pregnancy. Clin Obstet Gynecol. 2012;55:838–48.Google Scholar

Massad, LS, Einstein, MH, Huh, WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1–27. doi: 10.1097/LGT.0b013e318287d329Google Scholar

Broderick, D, Matityahu, D, Dudhbhai, M, et al. Histologic and colposcopic correlates of ASCUS Pap smears in pregnancy. J Low Genit Tract Dis. 2002;6:116–19.CrossRefGoogle ScholarPubMed

Muller, CY, Smith, HO. Cervical neoplasia complicating pregnancy. Obstet Gynecol Clin North Am. 2005;32:533–46. doi: 10.1016/j.ogc.2005.08.007Google Scholar

Van Calsteren, K, Vergote, I, Amant, F. Cervical neoplasia during pregnancy: Diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol. 2005;19:611–30. doi: 10.1016/j.bpobgyn.2005.03.002Google Scholar

Michael, CW, Esfahani, FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol. 1997;17:99–107.Google Scholar

Public Health England. Programme and Colposcopy Management. Guidelines for commissioners, screening providers and programme managers for NHS cervical screening. 2016.Google Scholar

Economos, K, Perez Veridiano, N, Delke, I, et al. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol. 1993;81:915–18.Google Scholar

Baldauf, JJ, Dreyfus, M, Ritter, J. Benefits and risks of directed biopsy in pregnancy. J Low Genit Tract Dis. 1997;1:214–20.Google Scholar

Kyrgiou, M, Koliopoulos, G, Martin-Hirsch, P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489–98. doi: 10.1016/S0140-6736(06)68181-6Google Scholar

Dunn, TS, Ginsburg, V, Wolf, D. Loop-cone cerclage in pregnancy: a 5-year review. Gynecol Oncol. 2003;90:577–80. doi: 10.1016/S0090-8258(03)00395-0Google Scholar

Paraskevaidis, E, Koliopoulos, G, Kalantaridou, S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol. 2002;104:67–9.Google Scholar

Yost, NP, Santoso, JT, McIntire, DD, et al. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol. 1999;93:359–62.Google Scholar

Ahdoot, D, Van Nostrand, KM, Nguyen, NJ, et al. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. Am J Obstet Gynecol. 1998;178:1116–20.CrossRefGoogle ScholarPubMed

American College of Obstetricians and Gynecologists. Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210–16. doi: 10.1097/AOG.0000000000002355Google Scholar

Elliott, P, Coppleson, M, Russell, P, et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer. 2000;10:42–52.CrossRefGoogle ScholarPubMed

Favero, G, Chiantera, V, Oleszczuk, A, et al. Invasive cervical cancer during pregnancy: laparoscopic nodal evaluation before oncologic treatment delay. Gynecol Oncol. 2010;118:123–7. doi: 10.1016/j.ygyno.2010.04.012Google Scholar

Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24:394–403. doi: 10.1097/IGC.0000000000000062Google Scholar

Berman, ML, Keys, H, Creasman, W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol .1984;19:8–16.Google Scholar

Prem, KA, Makowski, EL, McKelvey, JL. Carcinoma of the cervix associated with pregnancy. Am J Obstet Gynecol. 1966;95:99–108. doi: 10.1016/0002-9378(66)90634-XGoogle Scholar

Parasnis, H, Raje, B, Hinduja, IN. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med. 1992;38:183–5.Google ScholarPubMed

Itsukaichi, M, Kurata, H, Matsushita, M, et al. Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins. Gynecol Oncol. 2003;90:387–9.Google Scholar

Schmeler, KM, Frumovitz, M, Ramirez, PT. Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011;120:321–5. doi: 10.1016/j.ygyno.2010.12.352CrossRefGoogle Scholar

Salvo, G, Frumovitz, M, Pareja, R, et al. Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (≥2 cm) cervical cancer: bridging the gap to fetal viability. Gynecol Oncol. 2018;150:50–5. doi: 10.1016/j.ygyno.2018.05.021Google Scholar

Capilna, ME, Szabo, B, Becsi, J, et al. Radical trachelectomy performed during pregnancy: a review of the literature. Int J Gynecol Cancer. 2016;26:758–62. doi: 10.1097/IGC.0000000000000655Google Scholar

Takushi, M, Moromizato, H, Sakumoto, K, et al. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol. 2002;87:185–9.Google Scholar

Morice, P, Uzan, C, Gouy, S, et al. Gynaecological cancers in pregnancy. Lancet. 2012;379:558–69. doi: 10.1016/S0140-6736(11)60829-5Google Scholar

Peccatori, FA, Azim, HA, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi160–70. doi: 10.1093/annonc/mdt199Google Scholar

Amant, F, Van Calsteren, K, Halaska, MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256–64. doi: 10.1016/S1470-2045(11)70363-1Google Scholar

Zagouri, F, Sergentanis, TN, Chrysikos, D, et al. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;121:337–43. doi: 10.1097/AOG.0b013e31827c5822Google Scholar

Sood, AK, Sorosky, JI, Mayr, N, et al. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol. 2000;95:832–8.Google Scholar

Van der Vange, N, Weverling, G, Ketting, B, et al. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet Gynecol. 1995;85:1022–6. doi: 10.1016/0029-7844(95)00059-ZGoogle Scholar

Van den Broek, NR, Lopes, A, Ansink, A, et al. Microinvasive adenocarcinoma of the cervix implanting in an episiotomy scar. Gynecol Oncol. 1995;59:297–9. doi: 10.1006/gyno.1995.0025Google Scholar

Pavlidis, N, Pentheroudakis, G. Metastatic involvement of placenta and fetus in pregnant women with cancer. Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer. 2008;178:183–94.Google Scholar

Navrozoglou, I, Vrekoussis, T, Kontostolis, E, et al. Breast cancer during pregnancy: a mini-review. Eur J Surg Oncol. 2008;34:837–43.Google Scholar

Azim, HA Jr, Del Mastro, L, Scarfone, G, Peccatori, FA. Treatment of breast cancer during pregnancy: regimen selection, pregnancy monitoring and more. Breast. 2011;20:1–6.Google Scholar

Csonka, Y, Mosimann, A. Familien in der Schweiz – Statistischer Bericht 2017. Neuchâtel: Swiss Federal Statistical Office (Bundesamt für Statistik); 2017.Google Scholar

Cullinane, CA, Lubinski, J, Neuhausen, SL, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005;117:988e91.CrossRefGoogle ScholarPubMed

Valentini, A, Lubinski, J, Byrski, T, et al.; Hereditary Breast Cancer Clinical Study Group. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat. 2013;142:177–85.Google Scholar

Framarino-Dei-Malatesta, M, Piccioni, MG, Brunelli, R, et al. Breast cancer during pregnancy: a retrospective study on obstetrical problems and survival. Eur J Obstet Gynecol Reprod Biol. 2014;173:48–52.Google Scholar

Bonnier, P, Romain, S, Dilhuydy, JM, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Int J Cancer. 1997;72:720–7.Google Scholar

Shachar, SS, Gallagher, K, McGuire, K, et al. Multidisciplinary management of breast cancer during pregnancy. Oncologist. 2017;22:324–34.Google Scholar

Ring, AE, Smith, IE, Ellis, PA. Breast cancer and pregnancy. Ann Oncol. 2005;16:1855–60.Google Scholar

Rimawi, BH, Green, V, Lindsay, M. Fetal implications of diagnostic radiation exposure during pregnancy: evidence-based recommendations. Clin Obstet Gynecol. 2016;59:412–18.Google Scholar

Nicklas, A, Baker, M. Imaging strategies in the pregnant breast cancer patient. Semin Oncol. 2000;27:623–32.Google Scholar

Amant, F, Van Calsteren, K, Halaska, MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256–64.Google Scholar

Myers, KS, Green, LA, Lebron, L, Morris, EA. Imaging appearance and clinical impact of preoperative breast MRI in pregnancy-associated breast cancer. AJR Am J Roentgenol. 2017;209:177–83.Google Scholar

Yang, WT, Dryden, MJ, Gwyn, K, Whitman, GJ, Theriault, R. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology. 2006;239:52–60.Google Scholar

Howard-Anderson, J, Ganz, PA, Bower, JE, Stanton, AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104:386e405.Google Scholar

Gerstl, B, Sullivan, E, Ives, A, et al. Pregnancy outcomes after a breast cancer diagnosis: a systematic review and meta-analysis. Clin Breast Cancer. 2018;18:e79-e88.Google Scholar

Gropper, AB, Calvillo, KZ, Dominici, L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014;21:2506–11.Google Scholar

Michieletto, S, Saibene, T, Evangelista, L, et al. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer. Breast. 2014;23:19–25.Google Scholar

Mazonakis, M, Varveris, H, Damilakis, J, Theoharopoulos, N, Gourtsoyiannis, N. Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55:386–91.CrossRefGoogle ScholarPubMed

Loibl, S, Schmidt, A, Gentilini, O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1:1145–53.Google Scholar

Hahn, KM, Johnson, PH, Gordon, N. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–26.Google Scholar

Shalaby, M, Lasheen, SF, Talima, S; 232P. Pregnancy associated breast cancer spotlights. Ann Oncol. 2017;28:1.Google Scholar

Gadducci, A, Cosio, S, Fanucchi, A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 2003;23:5225–30.Google Scholar

Mir, O, Berveiller, P, Goffinet, F, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010;21:425–6.Google Scholar

Cheung, CY. Vascular endothelial growth factor activation of intramembranous absorption: a critical pathway for amniotic fluid volume regulation. J Soc Gynecol Invest. 2004;11:63–74.Google Scholar

Bader, AA, Schlembach, D, Tamussimo, KF, Pristauz, G, Petru, E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007 8:79–81.Google Scholar

Sekar, R, Stone, PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007;110:507–10.Google Scholar

Shrim, A, Garcia-Bournissen, F, Maxwell, C, Farine, D, Koren, G. Trastuzumab treatment for breast cancer during pregnancy. Can Fam Physician. 2008;54:31–2.Google Scholar

Witzel, ID, Müller, V, Harps, E, Janicke, F, Dewit, M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2008;19:191–2.Google Scholar

Gadducci, A, Cosio, S, Genazzani, AR. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol. 2007;23:625–31.Google Scholar

Badawy, A, Elnashar, A, El-Ashry, M, Shahat, M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91:694–7.Google Scholar

Blumenfeld, Z. Endocrine prevention of chemotherapy-induced ovarian failure. Future Oncol. 2016;12:1671–4.Google Scholar

Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009 Mar;18(3):311–19. doi:10.1089/jwh.2008.0857. PMID: 19281314; PMCID: PMC2858300.Google Scholar

Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist. 2006;1:422–34.Google Scholar

Beck-Fruchter, R, Weiss, A, Shalev, E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update. 2008;14(6):553–61.Google Scholar

Gerber, B, Stehle, H, Ricardo, F, et al. ZORO: A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37). J Clin Oncol. 2009;27:526.Google Scholar

von Wolff, M, Bruckner, T, Strowitzki, T, Germeyer, A. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations. J Assist Reprod Genet. 2018;35:1713–19.Google Scholar

Van der Ven, H, Liebenthron, J, Beckmann, M, et al.; FertiPROTEKT Network. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod. 2016;31:2031–41.Google Scholar

Brown, RT, Fuemmeler, B, Anderson, D, et al. Adjustment of children and their mothers with breast cancer. J Pediatr Psychol. 2007; Apr;32:297–308.Google Scholar

Smith, LH, Danielsen, B, Allen, ME, Cress, R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003 Oct;189(4):1128–35.Google Scholar

de Haan, J, Verheecke, M, Van Calsteren, K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–46.Google Scholar

Han, SN, Lotgerink, A, Gziri, MM, et al. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med. 2012 Aug 8;10:86.Google Scholar

Timmerman, D, Van Calster, B, Testa, A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol. 2016 Apr;214(4):424–37.CrossRefGoogle ScholarPubMed

Dauer, LT, Thornton, RH, Miller, DL, et al. Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe with Endorsement by the Canadian Interventional Radiology Association. J Vasc Interv Radiol. 2012 Jan;23(1):19–32.Google Scholar

Han, SN, Amant, F, Michielsen, K et al. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study. Eur Radiol. 2018 May;28(5):1862–74.Google Scholar

Ray, JG, Vermeulen, MJ, Bharatha, A, Montanera, WJ, Park, AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016 Sep 6;316(9):952–61.Google Scholar

Committee on Obstetric Practice. Guidelines for Diagnostic Imaging during Pregnancy and Lactation, ACOG Committee Opinion No 723. October 2017.Google Scholar

Han, SN, Amant, F, Cardonick, EH, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast Cancer Res Treat. 2018;168(2):551–7.Google Scholar

Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014 Mar;24(3):394–403.Google Scholar

Amant, F, Berveiller, P, Boere, I, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601–12.CrossRefGoogle ScholarPubMed

Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk, Green-top Guideline No 37a. London: Royal College of Obstetricians and Gynaecologists, 13 April 2015.Google Scholar

Berveiller, P, Marty, O, Vialard, F, Mir, O. Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer. Expert Opin Drug Metab Toxicol. 2016 May;12(5):523–31.Google Scholar

Calsteren, KV, Verbesselt, R, Devlieger, R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010 Dec;20(9):1456–64.Google Scholar

van Hasselt, JG, van Calsteren, K, Heyns, L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol. 2014 Oct;25(10):2059–65.Google Scholar

Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013 Jul 10;31(20):2532–9.Google Scholar

Zagouri, F, Sergentanis, TN, Chrysikos, D, Filipits, M, Bartsch, R. Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology. 2012;83(4):234–8.Google Scholar

Zagouri, F, Sergentanis, TN, Chrysikos, D, Bartsch, R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013 Feb;121(2 Pt 1):337–43.Google Scholar

Geijteman, EC, Wensveen, CW, Duvekot, JJ, van Zuylen, L. A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014 Aug;124(2Pt 2 Suppl 1):454–6.Google Scholar

Amant, F, Van Calsteren, K, Halaska, MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012 Mar;13(3):256–64.Google Scholar

Amant, F, Vandenbroucke, T, Verheecke, M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015 Nov 5;373(19):1824–34.Google Scholar

Pentheroudakis, G, Pavlidis, N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006 Jan;42(2):126–40.Google Scholar

Morice, P, Uzan, C, Gouy, S, Verschraegen, C, Haie-Meder, C. Gynaecological cancers in pregnancy. Lancet. 2012 Feb 11;379(9815):558–69.Google Scholar

Zanotti-Fregonara, P, Chastan, M, Edet-Sanson, A, et al. New fetal dose estimates from 18F-FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms. J Nucl Med. 2016 Nov;57(11):1760–3.Google Scholar

Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009 Jan 1;27(1):45–51.Google Scholar

Halaska, MJ, Uzan, C, Han, SN, et al. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy. Int J Gynecol Cancer. 2019 Mar 20;ijgc-2018-000103.Google Scholar

Xia, T, Gao, Y, Wu, B, Yang, Y. Clinical analysis of twenty cases of cervical cancer associated with pregnancy. J Cancer Res Clin Oncol. 2015 Sep;141(9):1633–7.Google Scholar

Fruscio, R, de Haan, J, Van Calsteren, K, et al. Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:108–17.Google Scholar

Gui, T, Cao, D, Shen, K, et al. Management and outcome of ovarian malignancy complicating pregnancy: an analysis of 41 cases and review of the literature. Clin Transl Oncol. 2013 Jul;15(7):548–54.Google Scholar

Nazer, A, Czuzoj-Shulman, N, Oddy, L, Abenhaim, HA. Incidence of maternal and neonatal outcomes in pregnancies complicated by ovarian masses. Arch Gynecol Obstet. 2015 Nov;292(5):1069–74.Google Scholar

Cardonick, E, Usmani, A, Ghaffar, S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010 Jun;33(3):221–8.Google Scholar

Peccatori, FA, Azim, HA Jr, Orecchia, R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24(Suppl 6):vi160–70.Google Scholar

Blake, EA, Kodama, M, Yunokawa, M, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:97–105.Google Scholar

Hannuna, KY, Putignani, L, Silvestri, E, et al. Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer. 2009 Dec;19(9):1580–4.Google Scholar

Lee, YY, Roberts, CL, Dobbins, T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG. 2012 Dec;119(13):1572–82.Google Scholar

Parazzini, F, Franchi, M, Tavani, A, Negri, E, Peccatori, FA. Frequency of pregnancy related cancer: a population based linkage study in Lombardy, Italy. Int J Gynecol Cancer. 2017 Mar;27(3):613–19.Google Scholar

Matsuo, K, Whitman, SA, Blake, EA, et al. Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:216–23.Google Scholar

Soo-Hoo, S, Luesley, D. Vulval and vaginal cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016 May;33:73–8.Google Scholar

Mitrou, S, Zarkavelis, G, Fotopoulos, G, Petrakis, D, Pavlidis, N. A mini review on pregnant mothers with cancer: a paradoxical coexistence. J Adv Res. 2016 Jul;7 (4):559–63.Google Scholar

Han, SN, Kesic, VI, Van Calsteren, K, Petkovic, S, Amant, F; ESGO ‘Cancer in Pregnancy’ Task Force. Cancer in pregnancy: a survey of current clinical practice.Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):18–23.Google Scholar

Amant, F, Han, SN, Gziri, MM, et al. Management of cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015 Jul;29(5):741–53.Google Scholar

De Geus, KF, Maggen, C, de Haan, J, Amant, F. Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists. Oncotarget. 2018 Aug 7;9(61):31795–6.Google Scholar

De Haan, J, Vandecaveye, V, Han, SN, Van de Vijver, KK, Amant, F. Difficulties with diagnosis of malignancies in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016 May; 33:19–32.Google Scholar

Van Calsteren, K, Amant, F. Cancer during pregnancy. Acta Obstet Gynecol Scand. 2014 May;93(5):443–6.Google Scholar

Ngu, SF, Ngan, HY. Chemotherapy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016 May;33:86–101.Google Scholar

De Haan, J, Verheecke, M, Van Calsteren, K, et al.; International Network on Cancer and Infertility Pregnancy (INCIP). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018 Mar;19(3):337–46.Google Scholar

Peccatori, FA, Fumagalli, M. Long and winding road of cancer and pregnancy: a need for action. J Clin Oncol. 2017 May 10;35(14):1499–1500.Google Scholar

Verheecke, M, Cortès Calabuig, A, Finalet Ferreiro, J, et al. Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction. Placenta. 2018 Apr;64:61–70.Google Scholar

Boere, I, Lok, C, Vandenbroucke, T, Amant, F. Cancer in pregnancy: safety and efficacy of systemic therapies. Curr Opin Oncol. 2017 Sep;29(5):328–34.Google Scholar

Stensheim, H, Moller, B, Van Dijk, T, Fossa, SD. Cause specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009;27:45–51.Google Scholar

Lishner, M, Avivi, I, Apperley, JF, et al. Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol. 2016 Feb 10;34(5):501–8.Google Scholar

Moshe, Y, Bentur, OS, Lishner, M, Avivi, I. The management of Hodgkin lymphomas in pregnancies. Eur J Haematol. 2017 Nov;99(5):385–91.Google Scholar

Zagouri, F, Dimitrakakis, C, Marinopoulos, S, Tsigginou, A, Dimopoulos, MA. Cancer in pregnancy: disentangling treatment modalities. ESMO Open. 2016 May 4;1(3):e000016.Google Scholar

Paydas, S. Management of hemopoietic neoplasias during pregnancy. Crit Rev Oncol Hematol. 2016 Aug;104:52–64.Google Scholar

Pereg, D, Koren, G, Lishner, M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Hematologica. 2007;92:1230–7.Google Scholar

Berman, E. Pregnancy in patients with chronic myeloid leukemia. J Natl Compr Canc Netw. 2018 May;16(5S):660–2.Google Scholar

Ali, S, Jones, GL, Culligan, DJ, et al. British Committee for Standards in Haematology Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol. 2015 Aug;170(4):487–95.Google Scholar

Verma, V, Giri, S, Manandhar, S, Pathak, R, Bhatt, VR. Acute promyelocytic leukemia during pregnancy: a systematic analysis of outcome. Leuk Lymphoma. 2016;57(3):616–22.Google Scholar

Vlijm-Kievit, A, Jorna, NGE, Moll, E, et al. Acute lymphoblastic leukemia during the third trimester of pregnancy. Leuk Lymphoma. 2018 May;59(5):1274–6.Google Scholar

De Haan, J, Lok, CA, de Groot, CJ, et al.; International Network on Cancer, Infertility and Pregnancy (INCIP). Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma. Melanoma Res. 2017 Jun;27(3):218–23.Google Scholar

De Haan, J, van Thienen, JV, Casaer, M, et al. Severe adverse reaction to vemurafenib in a pregnant woman with metastatic melanoma. Case Rep Oncol. 2018 Feb 15;11(1):119–24.Google Scholar

Yu, SS, Bischoff, LA. Thyroid cancer in pregnancy. Semin Reprod Med. 2016 Nov;34(6):351–5.Google Scholar

Boucek, J, de Haan, J, Halaska, MJ, et al.; International Network on Cancer, Infertility, and Pregnancy. Maternal and obstetrical outcome in 35 cases of well-differentiated thyroid carcinoma during pregnancy. Laryngoscope. 2018 Jun;128(6):1493–1500.Google Scholar

Modesti, C, Aceto, P, Masini, L, et al. Approach to thyroid carcinoma in pregnancy. Updates Surg. 2017 Jun;69(2):261–5.Google Scholar

Khaled, H, Al Lahloubi, N, Rashad, N. A review on thyroid cancer during pregnancy: Multitasking is required. J Adv Res. 2016 Jul; 7(4):565–70.Google Scholar

Kocián, P, De Haan, J, Cardonick, EH, et al.; Writing Committee of the International Network on Cancer, Infertility and Pregnancy (INCIP). Management and outcome of colorectal cancer during pregnancy: report of 41 cases. Acta Chir Belg. 2018 Jul;16:1–10.Google Scholar

Rogers, JE, Dasari, A, Eng, C. The treatment of colorectal cancer during pregnancy: cytotoxic chemotherapy and targeted therapy challenges. Oncologist. 2016 May;21(5):563–70.Google Scholar

Verheecke, M, Halaska, MJ, Lok, CA, et al.; ESGO Task Force ‘Cancer in Pregnancy’. Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature. Eur J Cancer. 2014 May;50(8):1462–71.Google Scholar

Knight, M, Kenyon, S, Brocklehurst, P, et al. eds. Saving Lives, Improving Mothers’ Care: Lessons Learned to Inform Future Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–2012. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.Google Scholar

Cantwell, R, Clutton-Brock, T, Cooper, G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1–203.Google Scholar

Draper, ES, Kurinczuk, JJ, Kenyon, S. eds. MBRRACE-UK Perinatal Confidential Enquiry: Term, Singleton, Intrapartum Stillbirth and Intrapartum-Related Neonatal Death. Leicester: Department of Health Sciences, University of Leicester; 2017.Google Scholar

Confidential Enquiry into Stillbirths and Deaths in Infancy: 4th Annual Report, 1 January–31 December 1995. London: Maternal and Child Health Research Consortium; 1997.Google Scholar

European Training Requirements in Obstetrics and Gynaecology, UEMS Section Obstetrics and Gynaecology / European Board and College of Obstetrics and Gynaecology, Standing Committee on Training and Assessment, Version 2018.Google Scholar

ACOG Simulations Working Group, www.acog.org/About-ACOG/ACOG-Departments/Simulations-Consortium?IsMobileSet=false.Google Scholar

Craig, C, Posner, GD. Developing a Canadian curriculum for simulation-based education in obstetrics and gynaecology: a Delphi study. J Obstet Gynaecol Can. 2017;39(9):757–63.Google Scholar

Royal College of Obstetricians and Gynaecologists. Run emergency obstetric skills and drills training, www.rcog.org.uk/en/careers-training/workplace-workforce-issues/improving-workplace-behaviours-dealing-with-undermining/undermining-toolkit/departmental-and-team-interventions/run-emergency-obstetric-skills-and-drills-training/.Google Scholar

Monod, C, Voekt, CA, Gisin, M, Gisin, S, Hoesli, IM. Optimization of competency in obstetrical emergencies: a role for simulation training. Arch Gynecol Obstet. 2014;289(4):733–8.Google Scholar

Reynolds, A, Ayres-de-Campos, D, Lobo, M. Self-perceived impact of simulation-based training on the management of real-life obstetrical emergencies. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):72–6.Google Scholar

Crofts, JF, Ellis, D, Draycott, TJ, et al. Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation centre and teamwork training. BJOG. 2007;114(12):1534–41.Google Scholar

Crofts, JF, Bartlett, C, Ellis, D, et al. Management of shoulder dystocia: skill retention 6 and 12 months after training. Obstet Gynecol. 2007;110(5):1069–74.Google Scholar

Crofts, JF, Bartlett, C, Ellis, D, et al. Training for shoulder dystocia: a trial of simulation using low-fidelity and high-fidelity mannequins. Obstet Gynecol. 2006;108(6):1477–85.Google Scholar

Ellis, D, Crofts, JF, Hunt, LP, et al. Hospital, simulation center, and teamwork training for eclampsia management: a randomized controlled trial. Obstet Gynecol. 2008;111(3):723–31.Google Scholar

Crofts, JF, Bartlett, C, Ellis, D, et al. Patient-actor perception of care: a comparison of obstetric emergency training using manikins and patient-actors. Qual Saf Health Care. 2008;17(1):20.Google Scholar

Draycott, T, Sibanda, T, Owen, L, et al. Does training in obstetric emergencies improve neonatal outcome? BJOG. 2006;113(2):177–82.Google Scholar

PROMPT: PRactical Obstetric Multi-Professional Training. www.promptmaternity.org/Google Scholar

Weiner, CP, Collins, L, Bentley, S, Dong, Y, Satterwhite, CL. Multi-professional training for obstetric emergencies in a U.S. hospital over a 7-year interval: an observational study. J Perinatol. 2016;36(1):19–24.Google Scholar

Shoushtarian, M, Barnett, M, McMahon, F, Ferris, J. Impact of introducing practical obstetric multi-professional training (PROMPT) into maternity units in Victoria, Australia. BJOG. 2014;121(13):1710–18.Google Scholar

Crofts, JF, Mukuli, T, Murove, BT, et al. Onsite training of doctors, midwives and nurses in obstetric emergencies, Zimbabwe. Bull World Health Organ. 2015;93(5):347–51.Google Scholar

Millde Luthander, C, Källen, K, Nyström, ME, et al. Results from the National Perinatal Patient Safety Program in Sweden: the challenge of evaluation. Acta Obstet Gynecol Scand. 2016;95(5):596–603.Google Scholar

Fransen, AF, van de Ven, J, Schuit, E, et al. Simulation-based team training for multi-professional obstetric care teams to improve patient outcome: a multicentre, cluster randomised controlled trial. BJOG. 2017;124(4):641–50.Google Scholar

Draycott, TJ, Crofts, JF, Ash, JP, et al. Improving neonatal outcome through practical shoulder dystocia training. Obstet Gynecol. 2008;112(1):14–20.Google Scholar

Crofts, JF, Lenguerrand, E, Bentham, GL, et al. Prevention of brachial plexus injury-12 years of shoulder dystocia training: an interrupted time-series study. BJOG. 2016;123(1):111–18.Google Scholar

Walsh, JM, Kandamany, N, Ni Shuibhne, N, et al. Neonatal brachial plexus injury: comparison of incidence and antecedents between 2 decades. Am J Obstet Gynecol. 2011;204(4):324.e1–.e6.Google Scholar

MacKenzie, IZ, Shah, M, Lean, K, et al. Management of shoulder dystocia: trends in incidence and maternal and neonatal morbidity. Obstet Gynecol. 2007;110(5):1059–68.Google Scholar

Siassakos, D, Hasafa, Z, Sibanda, T, et al. Retrospective cohort study of diagnosis-delivery interval with umbilical cord prolapse: the effect of team training. BJOG. 2009;116(8):1089–96.Google Scholar

Fuhrmann, L, Pedersen, TH, Atke, A, Møller, AM, Østergaard, D. Multidisciplinary team training reduces the decision-to-delivery interval for emergency caesarean section. Acta Anaesthesiol Scand. 2015;59(10):1287–95.Google Scholar

Draycott, T, Sagar, R, Hogg, S. The role of insurers in maternity safety. Best Pract Res Clin Obstet Gynaecol. 2015;29(8):1126–31.Google Scholar

Draycott, TJ, Collins, KJ, Crofts, JF, et al. Myths and realities of training in obstetric emergencies. Best Pract Res Clin Obstet Gynaecol. 2015;29(8):1067–76.Google Scholar

Yau, CWH, Pizzo, E, Morris, S, et al. The cost of local, multi-professional obstetric emergencies training. Acta Obstet Gynecol Scand. 2016;95(10):1111–19.Google Scholar

van de Ven, J, van Baaren, GJ, Fransen, AF, et al. Cost-effectiveness of simulation-based team training in obstetric emergencies (TOSTI study). Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:130–7.Google Scholar

Siassakos, D, Fox, R, Bristowe, K, et al. What makes maternity teams effective and safe? Lessons from a series of research on teamwork, leadership and team training. Acta Obstet Gynecol Scand. 2013;92(11):1239–43.Google Scholar

Nielsen, PE, Goldman, MB, Mann, S, et al. Effects of teamwork training on adverse outcomes and process of care in labor and delivery: a randomized controlled trial. Obstet Gynecol. 2007;109(1):48–55.Google Scholar

Siassakos, D, Fox, R, Crofts, JF, et al. The management of a simulated emergency: better teamwork, better performance. Resuscitation. 2011;82(2):203–6.Google Scholar

Siassakos, D, Bristowe, K, Draycott, TJ, et al. Clinical efficiency in a simulated emergency and relationship to team behaviours: a multisite cross-sectional study. BJOG. 2011;118(5):596–607.Google Scholar

Hunziker, S, Bühlmann, C, Tschan, F, et al. Brief leadership instructions improve cardiopulmonary resuscitation in a high-fidelity simulation: a randomized controlled trial. Crit Care Med. 2010;38(4):1086–91.Google Scholar

Bergh, A-M, Baloyi, S, Pattinson, RC. What is the impact of multi-professional emergency obstetric and neonatal care training? Best Pract Res Clin Obstet Gynaecol. 2015;29(8):1028–43.Google Scholar

Draycott, T. Not all training for obstetric emergencies is equal, or effective. BJOG. 2017;124(4):651.Google Scholar

Hattie, J. Visible Learning. Abingdon and New York: Routledge; 2009.Google Scholar